Blog Full Right Sidebar

Sun Pharma is moving forward with a $12 billion offer for Organon & Co. This acquisition would be the largest for an Indian pharma company. Sun Pharma is finalizing financing for the deal. Organon specializes in women’s health. The company is also facing competition from other global consortiums. This move signifies Sun Pharma’s ambition to grow in innovative drug research.Read More

Indian banks have largely exited their net open foreign exchange positions ahead of a regulatory deadline, reducing aggregate positions from $40 billion to an estimated $4-7 billion. This move, aimed at complying with central bank curbs, is expected to see the rupee trade in the 93/$ to 94.50/$ range with a depreciating bias.Read More

Financial services bore the brunt of foreign investor selling in the latter half of March, with outflows exceeding ₹60,000 crore, the highest since 2012. This broad-based selling, driven by valuation concerns and geopolitical uncertainty, saw significant withdrawals from banking, automobiles, and construction sectors.Read More

Banks are set to boost credit flow to MSMEs as regulators ease onboarding for the Trade Receivables Discounting System (TReDS). This move aims to improve liquidity and working capital efficiency for small businesses facing global economic strains. Revised guidelines and government mandates further support this shift towards dynamic, cash flow-based financing, crucial for timely payments and business growth.Read More

Indian equity markets saw profit booking on April 9, ending a five-day rally. Several companies like RIL, TCS, and IDFC First Bank are in focus due to news and Q4 results. Granules India faces US regulator scrutiny, while SpiceJet is ordered to pay $8 million to an engine lessor.Read More